Dizman, N., Tidwell, R. S., Sheth, R., Alhalabi, O., Corn, P. G., Campbell, M. T., Goswami, S., Johns, A., Jonasch, E., Lin, J. K., Shah, A. Y., Wang, J., Zurita, A. J., Gao, J., Tannir, N. M., Hahn, A. W., Msaouel, P. (2026). Ivonescimab in metastatic clear cell renal cell carcinoma (mccRCC) after immune checkpoint inhibitor therapy: The phase II IVORY trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps573